Healthy Plasma
About:Healthy Plasma - Human plasma collected from consented, clinically screened healthy donors and processed within one day of collection, in the anticoagulant your assay requires. Ideal as matched control material for protein, metabolite, and inflammatory marker comparison against disease states, and for coagulation, cell-free nucleic acid, and immunoassay method development. Bulk plasma is available.
About Healthy Plasma
Healthy Human Plasma for Control and Baseline Research
Healthy Plasma is collected from IRB-consented, clinically screened healthy donors and processed within one day of collection to preserve key analytes such as cytokines, proteins, and metabolites. It supports research into inflammatory pathways, immune profiling, and biomarker discovery as matched control material. Anticoagulant type and aliquot volume are configured per project and reported per lot. Bulk plasma is available.
Why Plasma from Healthy Donors
Plasma is the fluid fraction of anticoagulated blood, separated by centrifugation without allowing the blood to clot. That distinction from serum is not cosmetic; it determines which analytes survive and which assays the specimen is fit for.
- Because coagulation is prevented, fibrinogen and the clotting factors remain intact, making plasma the required matrix for coagulation and fibrinolysis research.
- No clot forms, so platelets are not activated during processing and platelet-derived mediators are not released into the fluid — a major source of artefact when serum is used for cytokine and growth factor measurement.
- Plasma is the conventional matrix for circulating cell-free nucleic acid and extracellular vesicle research, where cellular lysis during clotting would contaminate the analyte of interest.
- Anticoagulant choice is part of the experimental design: EDTA chelates divalent cations and is standard for nucleic acid work, citrate is used for coagulation testing, and heparin is used where downstream enzymatic activity must be preserved. Specifying the tube up front avoids an unusable specimen.
- Healthy plasma defines the baseline against which a disease-state signal is measured; without an identically collected and processed control arm, apparent biomarker differences may reflect pre-analytical handling rather than biology.
- Because our healthy and disease-state collections run under the same protocols and processing windows, pre-analytical variables are held constant across the comparison.
Donor Stratification Available
- Age band and sex assigned at birth, for demographic matching to a disease cohort
- Race and ethnicity
- Body mass index and smoking status where captured
- Medication-free donors, or donors on defined medication classes
- Blood type and infectious disease screening results, including viral serostatus where documented
- Anticoagulant type, where inventory permits
- Cohorts demographically matched to a specific disease-state collection available on request
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically screened healthy donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Anticoagulant type specified at order where inventory permits
- Custom aliquot volumes available upon request
- Volumes and lot-specific processing details reported per lot
De-identified Donor Data
- Verified healthy status following clinical screening
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications and allergies
- Additional demographic and screening metadata available on request
Applications
- Matched control arms for disease-state biomarker discovery and validation
- Cytokine, chemokine, and inflammation profiling
- Proteomic and metabolomic baseline characterisation
- Coagulation and fibrinolysis research with citrate collection
- Circulating cell-free nucleic acid and extracellular vesicle method development
- Immunoassay development, calibration, and matrix effect testing
- Reference range and normal distribution establishment for candidate analytes
- Controls for therapeutic candidate screening and pharmacokinetic method validation
Other Healthy Donor Specimen Types
- Healthy Serum
- Healthy Whole Blood
- Healthy PBMC
- Healthy Leukopak
- Healthy Bulk Plasma
- Healthy Skin Punch Biopsy
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering & Customization
Healthy plasma is available in standard and custom volumes. For pricing, availability, international orders, or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations. To browse other donor cohorts and collection formats, visit our human plasma page.
Applications
- Immunology and translational research
- Biomarker discovery and validation
- Drug screening and assay development
- Vaccine and infectious disease research
Product Features
- Research Use Only (RUO), Plasma
- Sourced from screened, consented donors
- Processed under validated SOPs
- QC tested for purity, viability, and sterility
- Processed within 24 hours of collection
- IRB-approved protocols with electronic informed consent
Donor Metadata
- Verified diagnosis and clinical history
- Demographic data: age, sex assigned at birth, race/ethnicity
- Medication and treatment background when available
Compliance and Quality Assurance
- IRB-approved collections and standardized procedures
- 21 CFR Part 11-compliant e-consent system
- HIPAA-compliant data management
Ordering & Customization
Human Plasma are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Where can I find your complete catalog?
You can find our full product catalog here.
How long can samples be stored?
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
What customization options are available?
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
Do you offer prospective collections?
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
What is the turnaround time for custom collections?
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Are samples collected under IRB-approved protocols?
YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Frequently Asked Questions
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.